RxDoctor Payments Data

Lauren Sheffield, PA

Physician Assistant · Lone Tree, CONPI 1588139349

Payments from drug & device makers

$6,009in general payments, 2019–2025

Across 114 payments — averaging $52.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Globus Medical$1K
  • Ferring Pharmaceuticals Inc.$607
  • Teleflex LLC$429
  • Astellas Pharma US Inc$341
  • Procept Biorobotics Corporation$303
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$1,16019%
  • Travel & lodging$1412%
  • Food & beverage$4,39773%
  • Education$3115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,009 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$222,853
Medicare patients
310
Services billed
4,498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron43$46,220
MyrbetriqMirabegron56$45,516
Abiraterone Acetate13$16,851
Estradiol48$3,329
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst104$2,936
Methenamine Hippurate25$2,022
Solifenacin Succinate22$1,322
Tamsulosin Hcl123$1,174
NitrofurantoinNitrofurantoin Macrocrystal21$927
Cephalexin74$829
Finasteride56$541
Testosterone Cypionate18$366
Oxybutynin Chloride ErOxybutynin Chloride16$301
Cefdinir12$249
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$71$46,22043 claims
Astellas Pharma US IncMyrbetriq$341$45,51656 claims
Janssen Scientific Affairs, LLCAbiraterone Acetate$236$16,85113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Lone Tree

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →